What’s the T with PrEP, the Stay Study, and the trans and gender non-conforming community?

This study is one of the first to focus exclusively on providing PrEP to the trans and gender non-conforming community. Trans and gender non-conforming people face many factors that affect their risk for HIV infection. We know this because the San Francisco Department of Public Health has been conducting research and delivering services to trans people for more than two decades.

The goal of this study is to offer the most recent advancement in HIV prevention—Pre-exposure Prophylaxis or PrEP—to trans and gender non-conforming people in the Bay Area.

This study is a partnership between four clinics that are leaders in providing trans-specific health care in the Bay Area and researchers at the San Francisco Department of Public Health. The Stay Study is funded by the California HIV/AIDS Research Program (CHRP).

Pre-Exposure Prophylaxis

PrEP is a daily pill (Truvada®) that protects HIV-negative people from HIV infection. Several large studies have shown daily use of PrEP can prevent new HIV infection by over 90%. PrEP will be provided free of charge as part of the Stay Study.

Real People.
Real Support.

Peer navigators at each of the clinics and can support you while taking PrEP. Anytime you need a question answered, or want someone to talk to, text or call us. We’ll get back to you as soon as we can. We’ll also send you a friendly text each week checking in to make sure things are going okay.

Reminders that
don't suck.

We’ll send reminders (disguised as funny texts or interesting facts about the trans community) for about 2 weeks to get you started. If you want to keep getting the texts, just let us know. We don’t want to be annoying.

The Stay Study
is Research.

When you join the study, we’ll ask you to participate in research activities to help us find out if our project helped you get on PrEP and supported you in taking your meds. You’ll also get paid for your time. You deserve it!